Drug Type Small molecule drug |
Synonyms SL 910102 |
Target |
Action antagonists |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC30H30N6O |
InChIKeyUIAQSYFAKRGALR-UHFFFAOYSA-N |
CAS Registry144756-71-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Phase 1 | France | - | |
Hypertension | Phase 1 | - | - | |
Atherosclerosis | Preclinical | France | - | |
Heart Failure | Preclinical | France | - |